Riverside Medical Center Performs First In-Patient Use of Biomaterial-Based HydroPICC® Dual Lumen Catheter
12. Dezember 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced that Riverside Medical Center, located just outside the Chicago area, was the first in the nation to...
Access Vascular Integrative Review Published in International Journal of Nursing and Healthcare Research Establishes Economic Impact of Biomaterial Catheters
31. Oktober 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications through its advanced biomaterial...
Journal of Infusion Nursing Publishes Access Vascular Data Showing Significantly Reduced Complication Rates for HydroMID
19. September 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications through its advanced biomaterial...
New Access Vascular Retrospective Data Review Demonstrates Midline Catheters Composed of Advanced Biomaterials May Improve Dwell Times
12. Juli 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today shared initial findings from a retrospective review of patient records that demonstrates an increase in dwell...
Access Vascular Inc. Named 2022 MedTech Breakthrough Award Winner
10. Mai 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced it has been named “Best New Technology Solution – Drug Delivery” in the 2022 MedTech Breakthrough...
Access Vascular Receives FDA Clearance for HydroPICC® Biomaterial-Based Dual-Lumen Catheter
05. Mai 2022 11:48 ET
|
Access Vascular
BILLERICA, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its HydroPICC®...
Access Vascular Inc. Wins 2022 Edison Award for Innovation
26. April 2022 10:32 ET
|
Access Vascular
BILLERICA, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced its biomaterial-based hydrophilic catheters received a Gold Award as the 2022 Edison Best New Product...
Access Vascular, Inc. Opens New Facility Outside Boston With Expanded Production Capacity to Meet Growing Demand for Its Biomaterial Devices
28. März 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., March 28, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications, today announced the opening of its...
Access Vascular Inc. Partners with Healthcare Insights to Develop New MedTech Value-Based Care Program
10. Februar 2022 08:00 ET
|
Access Vascular
BILLERICA, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), today announced its partnership with Healthcare Insights (HCIS) to build a value-based care program that can more...
Access Vascular Inc. Named 2022 BIG Innovation Award Winner
11. Januar 2022 12:44 ET
|
Access Vascular
BEDFORD, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications, today announced it has been named a...